JP2006514051A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514051A5
JP2006514051A5 JP2004565376A JP2004565376A JP2006514051A5 JP 2006514051 A5 JP2006514051 A5 JP 2006514051A5 JP 2004565376 A JP2004565376 A JP 2004565376A JP 2004565376 A JP2004565376 A JP 2004565376A JP 2006514051 A5 JP2006514051 A5 JP 2006514051A5
Authority
JP
Japan
Prior art keywords
group
alkyl
unsubstituted
disubstituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004565376A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514051A (ja
Filing date
Publication date
Priority claimed from US10/325,420 external-priority patent/US20040122067A1/en
Application filed filed Critical
Publication of JP2006514051A publication Critical patent/JP2006514051A/ja
Publication of JP2006514051A5 publication Critical patent/JP2006514051A5/ja
Pending legal-status Critical Current

Links

JP2004565376A 2002-12-20 2003-12-11 慢性心不全の治療 Pending JP2006514051A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/325,420 US20040122067A1 (en) 2002-12-20 2002-12-20 Treatment of chronic heart failure
PCT/US2003/039410 WO2004060489A2 (en) 2002-12-20 2003-12-11 Treatment of chronic heart failure

Publications (2)

Publication Number Publication Date
JP2006514051A JP2006514051A (ja) 2006-04-27
JP2006514051A5 true JP2006514051A5 (cg-RX-API-DMAC7.html) 2007-02-01

Family

ID=32593758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004565376A Pending JP2006514051A (ja) 2002-12-20 2003-12-11 慢性心不全の治療

Country Status (7)

Country Link
US (1) US20040122067A1 (cg-RX-API-DMAC7.html)
EP (1) EP1581308A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006514051A (cg-RX-API-DMAC7.html)
CA (1) CA2506719A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05006628A (cg-RX-API-DMAC7.html)
PL (1) PL375893A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004060489A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027887A2 (en) * 2003-09-17 2005-03-31 Cardimone Pharma Corporation Methods and compositions for improving endothelial function
WO2006121995A2 (en) * 2005-05-09 2006-11-16 Tap Pharmaceutical Products, Inc. Methods for treating nephrolithiasis
CA2669935A1 (en) * 2006-11-13 2008-05-29 Takeda Pharmaceuticals North America, Inc. Methods for preserving renal function using xanthine oxidoreductase inhibitors
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
RU2009131454A (ru) * 2007-01-19 2011-02-27 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
GB0909243D0 (en) * 2009-05-29 2009-07-15 Univ Dundee Angina treatment
IT1400309B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
IT1400609B1 (it) 2010-05-10 2013-06-14 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e metformina e loro uso.
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
IT1400310B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e statine e loro uso.
JP5978216B2 (ja) 2010-09-10 2016-08-24 タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド テオフィリンとフェブキソスタットの併用療法のための方法
US20170217948A1 (en) 2014-07-30 2017-08-03 Teijin Pharma Limited Xanthine oxidase inhibitor
JP6684264B2 (ja) * 2015-02-17 2020-04-22 株式会社三和化学研究所 心不全の予防又は治療のための医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2073981C (en) * 1990-11-30 2002-01-08 Shiro Kondo 2-arylthiazole derivatives and pharmaceutical composition thereof
AU1520699A (en) * 1997-11-07 1999-05-31 Johns Hopkins University, The Methods for treatment of disorders of cardiac contractility
CZ297264B6 (cs) * 1998-09-09 2006-10-11 Metabasis Therapeutics, Inc. Nové heteroaromatické inhibitory fruktóza-1,6-bisfosfatázy
DE69942009D1 (de) * 1998-10-15 2010-03-25 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
EP1212064A2 (en) * 1999-03-09 2002-06-12 Max-Delbrück-Centrum Für Molekulare Medizin Use of inhibitors of endotoxin for the treatment of heart failure and of cachexia

Similar Documents

Publication Publication Date Title
RU2481346C2 (ru) Ингибиторы фосфатидилинозитол-3-киназы
RU2395500C2 (ru) 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств
JP2022510313A5 (cg-RX-API-DMAC7.html)
JP2018507197A5 (cg-RX-API-DMAC7.html)
JP2020505396A5 (cg-RX-API-DMAC7.html)
JP2019512478A5 (cg-RX-API-DMAC7.html)
RU2006112593A (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 и/или syk
RU2006134003A (ru) Серосодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
RU2003132687A (ru) Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv
JP2008533191A5 (cg-RX-API-DMAC7.html)
JP2006143737A5 (cg-RX-API-DMAC7.html)
JP2014500295A5 (cg-RX-API-DMAC7.html)
HUP0100950A2 (hu) Ciklusos aminovegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítmények
RU2003116123A (ru) Амидоэфирзамещенные имидазохинолины
JP2004537564A5 (cg-RX-API-DMAC7.html)
JP2005539088A5 (cg-RX-API-DMAC7.html)
CA2671071A1 (en) Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
RU2005114021A (ru) Производные имидазола и их применение в качестве периферически-селективных ингибиторов дофамин-бета-гидролазы
JP2008505157A5 (cg-RX-API-DMAC7.html)
EA200500096A1 (ru) Гетеробиарильные производные в качестве ингибиторов матриксных металлопротеиназ
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
CA2458025A1 (en) Novel 4-aminofuropyrimidines and the use thereof
JP2012513390A5 (cg-RX-API-DMAC7.html)
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b